TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skye Bioscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
SKYE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Skye Bioscience, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

A class action lawsuit has been filed against Skye Bioscience alleging false and misleading statements about their drug nimacimab's effectiveness and prospects during the period of November 4, 2024 to October 3, 2025.

Insights
DNTUY   neutral

Mentioned in company analysis without specific performance indicators


SKYE   negative

Lawsuit alleges company made materially false statements about drug effectiveness, overstated clinical and commercial prospects, which suggests potential misconduct and potential financial harm to investors